A Study to Investigate Safety and Tolerability of SH3809 Tablet in Patients With Advanced Solid Tumors
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The primary objective is to determine the safety and tolerability of SH3809 in subjects with
advanced solid tumors. The second objective is to evaluate the PK profile and preliminary
efficacy of SH3809 in solid tumors.